The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for follicular lymphoma patients.
If you would like to know how to access our trials please click here
Trial Name |
Description |
Click for more information (external page) |
GEN3013 |
Phase 1/2 study using antibody GEN3013 to target CD20- expressing cells in patients with B cell non-Hodgkin lymphoma
|
|
ME-401-001 |
A phase 2 study of a new drug called ME-401 in people with relapsed or refractory follicular lymphoma. Suitable for patients with lymphoma which has come back after previous treatment
|
|
PARADIGME LYMRIT-37-01 |
A phase 2 trial comparing two different doses of Betalutin and lilotomab
|
|
PETReA |
A phase 3 trial testing whether PET scans can help make treatment decisions for people with follicular lymhoma
|
|
GO29781 |
A phase 1/1b trial testing mosunetuzumab, on its own or with atezolizumab. Suitable for patients with lymphoma which has come back after previous treatment
|
|
RiVa |
Phase 2 trial testing the combination of rituximab and varlilumab in people with high grade and low grade lymphomas
|
*Please note, we update this page fortnightly
With special thanks to the following: